ロード中...
Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insu...
保存先:
| 出版年: | Korean J Intern Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association of Internal Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6506746/ https://ncbi.nlm.nih.gov/pubmed/29172405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.374 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|